Dha vs epa
Pro Research Analysisby 
Searched over 200M research papers
Comparative Effects of DHA and EPA on Inflammation, Lipid Profiles, and Cardiometabolic Health
Introduction to DHA and EPA
Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are omega-3 fatty acids commonly found in fish oil. Both have been extensively studied for their health benefits, particularly in reducing inflammation and improving cardiovascular health. However, they exhibit distinct effects on various biological markers and health outcomes.
Inflammatory Response Modulation
Differential Effects on Cytokine Expression
DHA and EPA have been shown to modulate inflammatory responses differently. DHA supplementation significantly reduces pro-inflammatory cytokines such as TNFA, IL6, and MCP1, and also lowers IL10 expression relative to EPA . EPA, on the other hand, primarily lowers TNFA and decreases the ratios of TNFA/IL10 and MCP1/IL10, indicating a more targeted anti-inflammatory effect .
Gene Expression in Immune Cells
Both DHA and EPA influence gene expression related to inflammation. DHA increases the expression of PPARA and TNFA while decreasing CD14 expression. EPA similarly enhances TRAF3 and PPARA expression and lowers CD14 expression, but the variations in gene expression between the two are strongly correlated, suggesting similar but not identical pathways of action .
Lipid Profile and Cardiometabolic Health
Triglycerides and Lipogenesis
DHA is more effective than EPA in reducing serum triglycerides. DHA supplementation leads to a significant decrease in blood triglycerides and an increase in lipoprotein lipase (LPL) activity, whereas EPA does not show the same triglyceride-lowering effect due to concomitant increases in lipogenesis . This suggests that DHA has a more potent effect on lipid metabolism.
LDL and HDL Cholesterol
DHA also has a more profound impact on LDL cholesterol (LDL-C) and HDL cholesterol (HDL-C). DHA increases LDL-C concentrations and mean LDL particle size more than EPA, and it also leads to greater increases in HDL-C 45. These changes are significant in men but not in women, indicating a potential sex-specific response to DHA supplementation .
Blood Pressure and Inflammatory Markers
Blood Pressure
EPA and DHA have distinct effects on blood pressure. EPA significantly reduces systolic blood pressure (SBP), especially in individuals with dyslipidemia, while DHA significantly reduces diastolic blood pressure (DBP) in the same population . This indicates that both fatty acids can contribute to blood pressure regulation, albeit through different mechanisms.
C-Reactive Protein (CRP)
Both EPA and DHA reduce concentrations of C-reactive protein (CRP), a marker of inflammation, particularly in subjects with dyslipidemia and higher baseline CRP levels . This shared effect underscores their role in mitigating chronic inflammation.
Mental Health and Neuroprotection
Depression and Neuroinflammation
EPA appears to be more effective than DHA in improving depression-like behaviors and neuroinflammation. In a chronic stress-induced rat model, EPA was more potent in ameliorating depression-like behaviors, reducing corticosterone and cholesterol levels, and normalizing astrocyte and neurotrophin function . EPA also showed superior efficacy in reducing IL-6 and TNF-α levels, which are associated with neuroinflammation .
Conclusion
DHA and EPA, while both beneficial, exhibit distinct effects on inflammation, lipid profiles, blood pressure, and mental health. DHA tends to have a broader impact on reducing pro-inflammatory cytokines and improving lipid profiles, particularly in lowering triglycerides and increasing HDL-C. EPA, on the other hand, shows a more targeted anti-inflammatory effect and is more effective in reducing systolic blood pressure and improving depression-like behaviors. Understanding these differences can help tailor supplementation strategies to individual health needs.
Sources and full results
Most relevant research papers on this topic